BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32752568)

  • 1. Japanese Encephalitis Vaccine.
    Mileno MD
    R I Med J (2013); 2020 Aug; 103(6):49-50. PubMed ID: 32752568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Fischer M; Lindsey N; Staples JE; Hills S;
    MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices.
    Hills SL; Walter EB; Atmar RL; Fischer M;
    MMWR Recomm Rep; 2019 Jul; 68(2):1-33. PubMed ID: 31518342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Travel-acquired Japanese encephalitis and vaccination considerations.
    Pavli A; Maltezou HC
    J Infect Dev Ctries; 2015 Sep; 9(9):917-24. PubMed ID: 26409731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 2006 Aug; 81(34/35):331-40. PubMed ID: 16933380
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO
    Amicizia D; Zangrillo F; Lai PL; Iovine M; Panatto D
    J Prev Med Hyg; 2018 Mar; 59(1):E99-E107. PubMed ID: 29938245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.
    Erra EO; Kantele A
    Expert Rev Vaccines; 2015; 14(9):1167-79. PubMed ID: 26162529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
    Hegde NR; Gore MM
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO
    Jelinek T; Cromer MA; Cramer JP; Mills DJ; Lessans K; Gherardin AW; Barnett ED; Hagmann SHF; Askling HH; Kiermayr S; Kadlecek V; Eder-Lingelbach S; Taucher C; Dubischar KL
    Travel Med Infect Dis; 2018; 22():18-24. PubMed ID: 29549036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis.
    Jelinek T
    Expert Rev Vaccines; 2013 Aug; 12(8):859-69. PubMed ID: 23984958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japanese encephalitis vaccine for travelers: exploring the limits of risk.
    Shlim DR; Solomon T
    Clin Infect Dis; 2002 Jul; 35(2):183-8. PubMed ID: 12087525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Japanese encephalitis vaccine in children: recommendations of the advisory committee on immunization practices, 2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Nov; 62(45):898-900. PubMed ID: 24226626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Product review on the JE vaccine IXIARO.
    Firbas C; Jilma B
    Hum Vaccin Immunother; 2015; 11(2):411-20. PubMed ID: 25621812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region.
    Dubischar KL; Kadlecek V; Sablan JB; Borja-Tabora CF; Gatchalian S; Eder-Lingelbach S; Kiermayr S; Spruth M; Westritschnig K
    Pediatr Infect Dis J; 2017 Sep; 36(9):898-904. PubMed ID: 28430748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese Encephalitis Among Three U.S. Travelers Returning from Asia, 2003-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jul; 58(27):737-40. PubMed ID: 19609246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on Japanese encephalitis vaccine for children: United States, May 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):664-5. PubMed ID: 21617633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese encephalitis for a reference to international travelers.
    Oya A; Kurane I
    J Travel Med; 2007; 14(4):259-68. PubMed ID: 17617849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1993 Jan; 42(RR-1):1-15. PubMed ID: 8381504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert opinion on vaccination of travelers against Japanese encephalitis.
    Burchard GD; Caumes E; Connor BA; Freedman DO; Jelinek T; Jong EC; von Sonnenburg F; Steffen R; Tsai TF; Wilder-Smith A; Zuckerman J
    J Travel Med; 2009; 16(3):204-16. PubMed ID: 19538583
    [No Abstract]   [Full Text] [Related]  

  • 20. Japanese encephalitis: the need for a more effective vaccine.
    Marfin AA; Gubler DJ
    Lancet; 2005 Oct 15-21; 366(9494):1335-7. PubMed ID: 16226596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.